Note 14 - Loss Per Share

9 Months Ended

Jun. 30, 2024

Notes to Financial Statements

Earnings Per Share [Text Block]

NOTE 14 – LOSS PER SHARE

The following table sets forth the computation of basic and diluted earnings per share for the following periods:

	Three Months Ended						Nine Months Ended
	June 30,			June 30,			June 30,			June 30,
	2024			2023			2024			2023
Basic and diluted:
Net Income (loss) continuing operations	$	459,737		$	(1,770,404	)	$	(3,547,327	)	$	(7,063,270	)
Preferred dividends accrued		1,000,500						3,001,501
Preferred dividends paid		-			1,000,501			-			3,001,503
Net loss attributable to cbdMD Inc. common shareholders		(540,763	)		(2,770,904	)		(6,548,828	)		(10,064,773	)
Shares used in computing basic and diluted earnings per share		3,592,969			2,379,633			3,561,884			2,360,908
Loss per share Basic
Basic and diluted earnings per share		(0.15	)		(1.16	)		(1.84	)		(4.26	)

At June 30, 2024, 112,831 potential shares underlying options, unvested RSUs and warrants as well as 185,223 potential shares underlying series A preferred shares were excluded from the shares used to calculate diluted loss per share as their inclusion would be anti-dilutive. At  June 30, 2023, 94,948 potential shares underlying options, unvested RSUs and warrants as well as 185,223 potential shares underlying series A preferred shares, and 40,404 a360 shares subject to certain vesting requirement as well as total 283,593 of available shares and remaining commitment share under the ELOC were excluded from the shares used to calculate diluted loss per share as their inclusion would reduce net loss per share.